Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2022-04-22 Transaction in Own Shar…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 21/04/2022- 22/04/2022
Transaction in Own Shares Classification · 100% confidence The document is titled "REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A." and details the purchase of 40,000 treasury shares over two days (April 21-22, 2022). It explicitly reports on the company's transactions involving its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a report, it is not a major regulatory filing like 10-K or IR, but rather a specific disclosure about share repurchase activity.
2022-04-22 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 21/04/2022 - 22/04/2022
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE DI DIASORIN S.P.A.' (Weekly Information on the Share Buyback Program of DiaSorin S.p.A.). It details the number of shares purchased (n. 40.000 azioni proprie) during a specific period (21/04/2022 - 22/04/2022) and provides a detailed transaction log. This activity directly corresponds to the company buying back or selling its own shares, which matches the definition for 'Transaction in Own Shares' (POS). Although it is a detailed report, the core subject is the share repurchase program, making POS the most specific classification over a general regulatory filing (RNS).
2022-04-22 Italian
New proposal for resolution related to the remuneration of the Board of Statutory Auditors
Regulatory Filings Classification · 99% confidence The document is an 'Informazione Regolamentata' (Regulated Information) from DiaSorin, dated April 22, 2022. The subject ('Oggetto') is 'New proposal for resolution related to the remuneration of the Board of Statutory Auditors' filed ahead of a Shareholders' meeting on April 29, 2022. This concerns proposals being made for shareholder voting, specifically regarding director/auditor remuneration, which falls under the scope of proxy materials or governance documents related to a meeting. The specific content relates to remuneration proposals for the Board of Statutory Auditors, which strongly aligns with the definition of Remuneration Information (DEF 14A) or materials presented for a shareholder vote (PSI). Since it is a specific proposal regarding remuneration for auditors/directors being submitted for a vote at a meeting, DEF 14A (Remuneration Information) is the most precise fit, as it details compensation matters presented to shareholders. The document itself is an announcement of this proposal, but the core subject matter is remuneration disclosure for governance bodies.
2022-04-22 English
Nuova proposta di delibera sui compensi del Collegio Sindacale
AGM Information Classification · 95% confidence The document is a regulatory announcement (Informazione Regolamentata) from DiaSorin dated April 22, 2022. The subject ('Oggetto') is 'Nuova proposta di delibera sui compensi del Collegio Sindacale' (New proposal for resolution on the fees of the Board of Statutory Auditors) related to an upcoming Shareholders' Meeting (Assemblea degli Azionisti) on April 29, 2022. This announcement concerns a proposal regarding director/auditor compensation and governance structure ahead of a shareholder vote. This strongly aligns with materials presented or discussed at an Annual General Meeting (AGM) or related preparatory documents. Since the document explicitly discusses a proposal for a resolution ('proposta di delibera') concerning the compensation of the Board of Statutory Auditors (Collegio Sindacale) to be voted on at the AGM, it is most closely related to AGM materials. While it is an announcement, its specific content points directly to AGM proceedings rather than a general regulatory filing (RNS) or a proxy statement (PSI) which typically solicits votes. Given the focus on specific resolutions for the AGM, AGM-R is the most appropriate classification, as it covers presentations and materials shared during the AGM, which includes pre-meeting announcements about agenda items.
2022-04-22 Italian
Annual Financial Report at December 31, 2021
Annual Report Classification · 100% confidence The document is titled 'ANNUAL FINANCIAL REPORT DECEMBER 31, 2021' and contains comprehensive sections including a letter to shareholders, report on operations, corporate governance, non-financial statements, and full consolidated and statutory financial statements (income statements, balance sheets, cash flows, and notes). This matches the definition of an Annual Report (10-K). FY 2021
2022-04-21 English
RECTIFICATION - Communication on total amount of voting rights.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal communication from DiaSorin, dated April 21, 2022, titled "COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS PURSUANT TO ARTICLE 85-BIS, PARAGRAPH 4-BIS, OF CONSOB REGULATION NO. 11971/1999". It explicitly details the total number of shares and the corresponding number of voting rights as of a specific record date (April 20, 2022), distinguishing between ordinary shares and those with increased voting rights. This content directly relates to the official results or status of shareholder voting rights, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is a communication about voting rights, it is not the final result of a vote (like AGM-R) but a mandatory disclosure regarding the total voting power, making DVA the most specific fit.
2022-04-21 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.